Skip to main navigation Skip to search Skip to main content

B-cell activating factor, a predictor of antibody mediated rejection in kidney transplantation recipients

  • Wannarat Pongpirul
  • , Wiwat Chancharoenthana
  • , Krit Pongpirul
  • , Asada Leelahavanichkul
  • , Wipawee Kittikowit
  • , Kamonwan Jutivorakool
  • , Bunthoon Nonthasoot
  • , Yingyos Avihingsanon
  • , Somchai Eiam-Ong
  • , Kearkiat Praditpornsilpa
  • , Natavudh Townamchai
  • Chulalongkorn University
  • Johns Hopkins Bloomberg School of Public Health
  • Faculty of Medicine, Chulalongkorn University

Research output: Contribution to journal › Article › peer-review

26 Citations (Scopus)

Abstract

Aim: Donor-specific antibody (DSA) is a widely-used biomarker for antibody-mediated rejection (ABMR) but correctly indicates only 30–40% of patients with ABMR. Additional biomarkers of ABMR in kidney transplant recipients are needed. Methods: All 68 kidney transplanted-recipients enrolled in this study were negative for graft rejection as determined by surveillance-biopsy ELISA at day 7 post-transplantation. Allograft biopsy was then performed at 6 months post-transplantation for subclinical-ABMR detection. Recipients were stratified by pre-transplant DSA and BAFF at day 7 into four groups. Results: During the study period, 13.2% of the recipients demonstrated subclinical-ABMR at 6 months, without patient with clinical ABMR presentations. Overall mean BAFF at day 7 was 393 pg/mL (95% CI = 316–471 pg/mL). The optimal cut-off value for low vs. high BAFF level was 573 pg/mL, with sensitivity and specificity at 77.8% and 88.1%, respectively. Fifty percent of recipients with high BAFF at day 7 (14 patients) and only 3.7% of patients with low BAFF demonstrated ABMR (P < 0.05). Indeed, ABMR was more common in patients high BAFF level (hazard ratio = 7.30; 95% CI = 3.77–14.15). The prevalence of ABMR among negative pre-transplant DSA/low BAFF, positive DSA/low BAFF, negative DSA/high BAFF, and positive DSA/ high BAFF recipients were 4.4, 0, 37.5 and 66.7%, respectively (P < 0.05). Conclusions: Post-transplant ABMR can be predicted by perioperative serum BAFF level. Together with DSA testing, BAFF provides additional predictive value for ABMR.

Original languageEnglish
Pages (from-to)169-174
Number of pages6
JournalNephrology
Volume23
Issue number2
DOIs
Publication statusPublished - Feb 2018
Externally publishedYes

Keywords

  • B-cell activating factor
  • Donor specific antibody
  • Kidney transplantation
  • antibody mediated rejection

Fingerprint

Dive into the research topics of 'B-cell activating factor, a predictor of antibody mediated rejection in kidney transplantation recipients'. Together they form a unique fingerprint.

Cite this